secwatch.observer — SEC 8-K summary
======================================

Issuer:     MIMEDX GROUP, INC. (MDXG)
CIK:        0001376339
Form:       8-K
Filed at:   2022-11-17T23:59:59+00:00
Accession:  0001193125-22-287241
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MiMedx attends Canaccord conference with standard investor presentation
-----------------------------------------------------------------------

- Executives attending Canaccord MedTech Forum on Nov 17, 2022; slide deck furnished as Exhibit 99.1.
- Slide deck titled 'A Pioneer & Leader in Placental Biologics'; no new financial data disclosed.
- Filing under Regulation FD; information not deemed filed or incorporated by reference.
- No material operational or financial updates provided in the 8-K or exhibit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1376339/000119312522287241/0001193125-22-287241-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1376339/000119312522287241/d773724d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-287241

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer